Sphingomyelinase dependent apoptosis of dendritic cells following treatment with amyloid peptides

Journal of Neuroimmunology

Volumn 219, Issue 1-2, 2010, Pages 81-89

  Xuan, Nguyen Thi ^a   Shumilina, Ekaterina ^a   Kempe, Daniela S ^a   Gulbins, Erich ^b   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

A 1 42; Amyloid peptide; Cell death; Ceramide; IAPP; Phosphatidylserine

Indexed keywords

AMITRIPTYLINE; AMYLIN; AMYLOID BETA PROTEIN[1-42]; CASPASE 3; CASPASE 8; CERAMIDE; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; PHOSPHATIDYLSERINE; SMALL INTERFERING RNA; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AMYLOID; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; ANNEXIN A5; APOPTOSIS; BONE MARROW; CASPASE 3; CASPASE 8; DENDRITIC CELLS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; RNA, SMALL INTERFERING; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77249094452     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.12.002     Document Type: Article

References (48)

1. Abdul H.M., Calabrese V., Calvani M., Butterfield D.A. Acetyl-l-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J. Neurosci. Res 2006, 84:398-408.
2. Adler H.S., Steinbrink K. Tolerogenic dendritic cells in health and disease: friend and foe!. Eur. J. Dermatol. 2007, 17:476-491.
3. Ashany D., Savir A., Bhardwaj N., Elkon K.B. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J. Immunol. 1999, 163:5303-5311.
4. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
5. Bentzen P.J., Lang E., Lang F. Curcumin induced suicidal erythrocyte death. Cell. Physiol. Biochem. 2007, 19:153-164.
6. Butler P.C., Chou J., Carter W.B., Wang Y.N., Bu B.H., Chang D., Chang J.K., Rizza R.A. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 1990, 39:752-756.
7. Butovsky O., Kunis G., Koronyo-Hamaoui M., Schwartz M. Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. Eur. J. Neurosci. 2007, 26:413-416.
8. Ciaramella A., Sanarico N., Bizzoni F., Moro M.L., Salani F., Scapigliati G., Spalletta G., Caltagirone C., Bossu P. Amyloid beta peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells. Neurobiol. Aging 2009, 30:210-221.
9. Czeloth N., Bernhardt G., Hofmann F., Genth H., Forster R. Sphingosine-1-phosphate mediates migration of mature dendritic cells. J. Immunol. 2005, 175:2960-2967.
10. Donnini S., Cantara S., Morbidelli L., Giachetti A., Ziche M. FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium. Cell Death Differ. 2006, 13:1088-1096.
11. Dubsky P., Ueno H., Piqueras B., Connolly J., Banchereau J., Palucka A.K. Human dendritic cell subsets for vaccination. J. Clin. Immunol. 2005, 25:551-572.
12. Eikelenboom P., Veerhuis R., Familian A., Hoozemans J.J., van Gool W.A., Rozemuller A.J. Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications. Neurodegener. Dis. 2008, 5:190-193.
13. Franchi L., Malisan F., Tomassini B., Testi R. Ceramide catabolism critically controls survival of human dendritic cells. J. Leukoc. Biol. 2006, 79:166-172.
14. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
15. Gulbins E., Szabo I., Baltzer K., Lang F. Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:7661-7666.
16. Gulbins E., Jekle A., Ferlinz K., Grassme H., Lang F. Physiology of apoptosis. Am. J. Physiol. Renal Physiol. 2000, 279:F605-F615.
17. Haataja L., Gurlo T., Huang C.J., Butler P.C. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr. Rev. 2008, 29:303-316.
18. Huang J., May J.M. Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid. Brain Res. 2006, 1097:52-58.
19. Huang C.J., Lin C.Y., Haataja L., Gurlo T., Butler A.E., Rizza R.A., Butler P.C. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 2007, 56:2016-2027.
20. Huwiler A., Pfeilschifter J. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. Curr. Pharm. Des 2006, 12:4625-4635.
21. Janson J., Laedtke T., Parisi J.E., O'Brien P., Petersen R.C., Butler P.C. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004, 53:474-481.
22. Josien R., Li H.L., Ingulli E., Sarma S., Wong B.R., Vologodskaia M., Steinman R.M., Choi Y. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 2000, 191:495-502.
23. Jung I.D., Lee J.S., Kim Y.J., Jeong Y.I., Lee C.M., Lee M.G., Ahn S.C., Park Y.M. Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen-activated protein kinase. Immunology 2007, 121:533-544.
24. Konarkowska B., Aitken J.F., Kistler J., Zhang S., Cooper G.J. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J. 2006, 273:3614-3624.
25. Lang K.S., Myssina S., Brand V., Sandu C., Lang P.A., Berchtold S., Huber S.M., Lang F., Wieder T. Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ. 2004, 11:231-243.
26. Lang K.S., Recher M., Junt T., Navarini A.A., Harris N.L., Freigang S., Odermatt B., Conrad C., Ittner L.M., Bauer S., Luther S.A., Uematsu S., Akira S., Hengartner H., Zinkernagel R.M. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 2005, 11:138-145.
27. Lang P.A., Huober J., Bachmann C., Kempe D.S., Sobiesiak M., Akel A., Niemoeller O.M., Dreischer P., Eisele K., Klarl B.A., Gulbins E., Lang F., Wieder T. Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel. Cell. Physiol. Biochem. 2006, 18:151-164.
28. Lang P.A., Schenck M., Nicolay J.P., Becker J.U., Kempe D.S., Lupescu A., Koka S., Eisele K., Klarl B.A., Rubben H., Schmid K.W., Mann K., Hildenbrand S., Hefter H., Huber S.M., Wieder T., Erhardt A., Haussinger D., Gulbins E., Lang F. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 2007, 13:164-170.
29. Leverkus M., Walczak H., McLellan A., Fries H.W., Terbeck G., Brocker E.B., Kampgen E. Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis. Blood 2000, 96:2628-2631.
30. Lundqvist A., Nagata T., Kiessling R., Pisa P. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L). Cancer Immunol. Immunother. 2002, 51:139-144.
31. Malaplate-Armand C., Florent-Bechard S., Youssef I., Koziel V., Sponne I., Kriem B., Leininger-Muller B., Olivier J.L., Oster T., Pillot T. Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol. Dis. 2006, 23:178-189.
32. Manuel S.L., Rahman S., Wigdahl B., Khan Z.K., Jain P. Dendritic cells in autoimmune diseases and neuroinflammatory disorders. Front. Biosci. 2007, 12:4315-4335.
33. Matveyenko A.V., Butler P.C. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 2006, 55:2106-2114.
34. Newsholme P., Keane D., Welters H.J., Morgan N.G. Life and death decisions of the pancreatic beta-cell: the role of fatty acids. Clin. Sci. (Lond.) 2007, 112:27-42.
35. Nicolay J.P., Schneider J., Niemoeller O.M., Artunc F., Portero-Otin M., Haik G., Thornalley P.J., Schleicher E., Wieder T., Lang F. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell. Physiol. Biochem. 2006, 18:223-232.
36. Nicolay J.P., Gatz S., Liebig G., Gulbins E., Lang F. Amyloid induced suicidal erythrocyte death. Cell. Physiol. Biochem. 2007, 19:175-184.
37. Ohsawa H., Kanatsuka A., Yamaguchi T., Makino H., Yoshida S. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem. Biophys. Res. Commun. 1989, 160:961-967.
38. Park H.Y., Park J.I., Baek D.W., Lee S.Y., Lee M.J., Jin J.O., Kim J.W., Hong Y.S., Lee Y.H., Kwak J.Y. Modulation of neutrophil apoptosis by beta-amyloid proteins. Int. Immunopharmacol. 2006, 6:1061-1069.
39. Ran Q., Gu M., Van Remmen H., Strong R., Roberts J.L., Richardson A. Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity. J. Neurosci. Res. 2006, 84:202-208.
40. Raynaud F., Marcilhac A. Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FEBS J. 2006, 273:3437-3443.
41. Sallusto F., Nicolo C., De Maria R., Corinti S., Testi R. Ceramide inhibits antigen uptake and presentation by dendritic cells. J. Exp. Med. 1996, 184:2411-2416.
42. Schmitt T.L., Steger M.M., Pavelka M., Grubeck-Loebenstein B. Interactions of the Alzheimer beta amyloid fragment (25-35) with peripheral blood dendritic cells. Mech. Ageing Dev. 1997, 94:223-232.
43. Seifarth C.C., Hinkmann C., Hahn E.G., Lohmann T., Harsch I.A. Reduced frequency of peripheral dendritic cells in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 2008, 116:162-166.
44. Uno S., Imagawa A., Okita K., Sayama K., Moriwaki M., Iwahashi H., Yamagata K., Tamura S., Matsuzawa Y., Hanafusa T., Miyagawa J., Shimomura I. Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia 2007, 50:596-601.
45. Wang J., Zheng L., Lobito A., Chan F.K., Dale J., Sneller M., Yao X., Puck J.M., Straus S.E., Lenardo M.J. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999, 98:47-58.
46. Yoon J.W., Jun H.S. Autoimmune destruction of pancreatic beta cells. Am. J. Ther. 2005, 12:580-591.
47. Yu M.S., Suen K.C., Kwok N.S., So K.F., Hugon J., Chuen-Chung C.R. Beta-amyloid peptides induces neuronal apoptosis via a mechanism independent of unfolded protein responses. Apoptosis 2006, 11:687-700.
48. Zhang Y., Ranta F., Tang C., Shumilina E., Mahmud H., Foller M., Ullrich S., Haring H.U., Lang F. Sphingomyelinase dependent apoptosis following treatment of pancreatic beta-cells with amyloid peptides Abeta(1-42) or IAPP. Apoptosis 2009, 14:878-889.